01 1Amphastar Nanjing Pharmaceuticals, Inc.
01 1Insulin Aspart
01 1U.S.A
NDC Package Code : 52221-115
Start Marketing Date : 2015-08-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
23
PharmaCompass offers a list of Insulin aspart API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Insulin aspart manufacturer or Insulin aspart supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Insulin aspart manufacturer or Insulin aspart supplier.
PharmaCompass also assists you with knowing the Insulin aspart API Price utilized in the formulation of products. Insulin aspart API Price is not always fixed or binding as the Insulin aspart Price is obtained through a variety of data sources. The Insulin aspart Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NovoMix 30 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NovoMix 30, including repackagers and relabelers. The FDA regulates NovoMix 30 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NovoMix 30 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NovoMix 30 supplier is an individual or a company that provides NovoMix 30 active pharmaceutical ingredient (API) or NovoMix 30 finished formulations upon request. The NovoMix 30 suppliers may include NovoMix 30 API manufacturers, exporters, distributors and traders.
click here to find a list of NovoMix 30 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NovoMix 30 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NovoMix 30 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NovoMix 30 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NovoMix 30 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NovoMix 30 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NovoMix 30 suppliers with NDC on PharmaCompass.
We have 1 companies offering NovoMix 30
Get in contact with the supplier of your choice:
